Основные показатели сайта

Возраст доменаn/a
Дата окончанияn/a
ИКСn/a
Страниц в Googlen/a
Страниц в Яндексеn/a
Dmozn/a
Яндекс Каталогn/a
Alexa Traffic Rankn/a
Alexa Countryn/a
История изменения показателейАвторизация

scrip.pharmaintelligence.informa.com

Идет сбор информации... Обновить

Анализ сайта

Title

Scrip | In-Depth Insights Beyond the Headlines

Keywords

n/a

Description

Discover essential insights and analysis for the pharmaceutical industry with Scrip. Stay updated on trends, innovations, and market intelligence.

Кодировка

UTF-8

Размер страницы

304.51 КБ

Количество слов

512

Длина текста на странице

3 824 симв.

Длина текста без пробелов

3 225 симв.

<H1>

  • Scrip - Pharma News And Expert Analysis For Commercial Decision Makers since 197...
  • Trending Stories

<H2>

  • The Business Of Obesity
  • Lilly’s Amylin Combo Could Be Best Weight Loss Drug Yet
  • Interviews
  • Focus On Asia
  • GSK’s Zejula Faces Patent Challenge By Natco In India
  • Data Analysis
  • Latest Articles
  • Podcasts
  • R&D
  • Business
  • Scrip Originals
  • About
  • Account
  • More

<H3>

    Анализ текста

    • 2.54% ( 13 ) with
    • 2.34% ( 12 ) scrip
    • 1.76% ( 9 ) insight
    • 1.37% ( 7 ) drug
    • 1.37% ( 7 ) opens
    • 1.37% ( 7 ) phase
    • 1.37% ( 7 ) window
    • 0.98% ( 5 ) data
    • 0.98% ( 5 ) watch
    • 0.78% ( 4 ) asia
    • 0.78% ( 4 ) more
    • 0.78% ( 4 ) raised
    • 0.59% ( 3 ) abbvie
    • 0.59% ( 3 ) about
    • 0.59% ( 3 ) analysis
    • 0.59% ( 3 ) atopic
    • 0.59% ( 3 ) business
    • 0.59% ( 3 ) commercial
    • 0.59% ( 3 ) company
    • 0.59% ( 3 ) dermatitis

    Идет сбор информации... Обновить

    Идет сбор информации... Обновить

    Вы можете разместить у себя кнопку, которая будет показывать значение тИЦ и ПР для вашего сайта. Для этого скопируйте приведенный выше код кнопки и вставьте его в html-код своей страницы.

    Если Вы хотите выбрать другой дизайн информера, нажмите здесь.

    Идет сбор информации... Обновить

    Внешние ссылки главной страницы ( 19 ) 
    insights.citeline.com/partnered-content/Partner Insights Opens in new window
    discover.pharmaignite.com/Insight-advertising-enquiries-SCRI...Advertise Opens in new window
    x.com/NorstellaCoTwitter feed
    linkedin.com/company/citeline/RSS feed
    insights.citeline.com/arc/outboundfeeds/rss/RSS feed
    podcasts.apple.com/us/channel/norstella/id6764757902Podcast
    open.spotify.com/show/3DTc3eIh4xI6pVOd6DdO67Spotify
    citeline.com/en/solutions/news-and-insightsAbout Us Opens in new window
    citeline.com/en/products-services/marketing/pharma-igniteAdvertise Opens in new window
    platform.evaluate.com/app/Evaluate Home
    citeline.com/en/app-insights-trialStart Free Trial Opens in new window
    insights.citeline.com/scrip/perspectives/Scrip Perspectives
    insights.citeline.com/in-vivo/outlook/scrip-100/Scrip 100 Ranking
    insights.citeline.com/scrip/focus-on-asia/scrip-asia-100/Scrip Asia 100
    insights.citeline.com/scrip/conferences/Conferences
    insights.citeline.com/scrip/leadership/executives-on-the-mov...Executives On The Move
    insights.citeline.com/scrip/r-and-d/pipeline-watch/Pipeline Watch
    norstella.com/terms-of-useTerms and Conditions Opens in new window
    norstella.com/privacy-center/Privacy Policy Opens in new window
    Внутренние ссылки главной страницы ( 63 ) 
    /Home
    /pink-sheetPink Sheet
    /scripScrip
    /medtech-insightMedtech Insight
    /hbw-insightHBW Insight
    /generics-bulletinGenerics Bulletin
    /in-vivoIn Vivo
    /scrip/focus-on-asia/chinaChina
    /scrip/therapeutic-category/alimentary-metabolic/obesityObesity
    /scrip/digital-technologies/aiAI
    /scrip/drug-pricingDrug Pricing
    /scrip/advanced-therapiesCell & Gene Therapies
    /scrip/business/dealsDeals
    /scrip/business/financingFinancing
    /scrip/business/earningsEarnings
    /scrip/business/strategyCommercial Strategy
    /scrip/new-productsApprovals & Launches
    /scrip/r-and-d/clinical-trialsTrial Results
    /scrip/market-accessMarket Access
    /scrip/therapeutic-category/anticancerCancer
    /scrip/therapeutic-category/immunologicalImmune Disorders
    /scrip/therapeutic-category/cardiovascularCardiovascular
    /scrip/therapeutic-category/neurologicalNeurological
    /scrip/rare-diseasesRare Diseases
    /scrip/leadership/interviewsInterviews
    /scrip/market-intelligence/data-insightsData Insights
    /scrip/scrip-asksScrip Asks
    /scrip/market-snapshotDisease Landscapes
    /scrip/focus-on-asia/japanJapan
    /scrip/focus-on-asia/south-koreaSouth Korea
    /scrip/focus-on-asia/indiaIndia
    /scrip/focus-on-asia/scrip-asia-100Scrip Asia 100
    /scrip/r-and-d/pipeline-watchPipeline Watch
    /scrip/business/financing/finance-watchFinance Watch
    /scrip/business/deals/deal-watchDeal Watch
    /scrip/business/stock-watchStock Watch
    /scrip/market-intelligence/top-drugsTop Selling Drugs
    /scrip/market-intelligence/company-rankingsCompany Rankings
    /scrip/leadership/executives-on-the-moveExecutive Moves
    /scrip/podcastsPodcasts
    /scrip/conferencesConference Coverage
    /scrip/perspectivesView
    /scrip/r-and-d/clinical-trials/lillys-amylin-combo-could-be-...Lilly’s Amylin Combo Could Be Best Weight Loss Drug Yet
    /authors/andrew-mcconaghie/Andrew McConaghie
    /scrip/therapeutic-category/cardiovascular/bms-keeps-its-car...<img>
    /authors/mandy-jackson/Mandy Jackson
    /scrip/therapeutic-category/immunological/merck-cos-phase-ii...<img>
    /authors/jessica-merrill/Jessica Merrill
    /scrip/r-and-d/clinical-trials/abbvie-has-eye-on-dupixent-an...<img>
    /authors/joseph-haas/Joseph Haas
    /scrip/business/strategy/lillys-ebglyss-to-take-on-dupixent-...<img>
    /authors/alaric-dearment/Alaric DeArment
    /scrip/focus-on-asia/india/gsks-zejula-faces-patent-challeng...GSK’s Zejula Faces Patent Challenge By Natco In India
    /authors/anju-ghangurde/Anju Ghangurde
    /meet-the-teamMeet The Team
    /meet-the-team/Meet the Team
    /editorial-standards/Editorial Standards
    /award-winning-journalism/Award-Winning Journalism 
    /help/Help
    /contact-us/Contact Us
    /my-account/contact-information/My Account
    /my-view-page/My View
    /my-account/email-preferences/Email Preferences

    Идет сбор информации... Обновить

    IP адреса

    104.18.36.19

    США - 172.64.151.237

    Организация

    CloudFlare

    Интернет провайдер

    CloudFlare

    HTTP/2 200
    content-type: text/html; charset=utf-8
    server: openresty
    x-arc-cache-tag: fusion-norstella-index-engine-6,fusion-did-norstella-index-engine-163,fusion-pt-norstella-index-engine-page,fusion-ptid-norstella-index-engine-pQbqmUJYiNNxS57u,fusion-template-id-norstella-index-pQbqmUJYiNNxS57u,url-norstella-index-30fd574f,url-norstella-insights-index-30fd574f
    x-arc-pb-mx-id: 00000000
    x-arc-pb-request-id: ca2fa2c3-5d17-42eb-bd3a-06d2b34b67fd
    etag: W/"4afcc-us6fMR4hmcSlr2wa45EghsUMs6w"
    x-arc-pb-edge: 0
    last-modified: Thu, 01 Oct 2026 03:15:58 GMT
    x-akamai-transformed: 9 56932 0 pmb=mRUM,2
    cache-control: private, max-age=60
    expires: Thu, 01 Oct 2026 03:18:06 GMT
    date: Thu, 01 Oct 2026 03:17:06 GMT
    server-timing: cdn-cache; desc=HIT
    server-timing: edge; dur=77
    server-timing: origin; dur=0
    content-security-policy: upgrade-insecure-requests
    x-arc-ttl: -1
    x-arc-request-id: 0.cf53d117.1790824626.138f55d
    x-arc-edgecontroller: 1.8.5
    server-timing: ak_p; desc="1790824626540_399594447_20510045_7987_57048_6_0_15";dur=1

    Проиндексирован

    Ссылаются

    Дополнительные ссылки

    Ссылка на отчет


    Анализ сайта


      Кнопка в Вашем браузере

      Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"

      Анализ сайта